Clinical trial
Multicenter, Randomized, Double-blind, Active Control, Parallel, Non-inferior, Phase 4 Clinical Trial to Assess Efficacy and Safety of Laybon Tab. in Patients With Knee Osteoarthritis
NCT07203547 is registered in ClinicalTrials.gov with Mather's Pharm. Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter, Randomized, Double-blind, Active Control, Parallel, Non-inferior, Phase 4 Clinical Trial to Assess Efficacy and Safety of Laybon Tab. in Patients With Knee Osteoarthritis
- Lead sponsor
- Mather's Pharm. Co., Ltd.
- Phase
- Phase 4
- Overall status
- Not yet recruiting
- Start date
- December 31, 2025
- Completion date
- March 31, 2028
- Enrollment
- 172 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.